![Gary Acton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Gary Acton worked as a Managing Director for the European Region at CTI BioPharma Corp.
He was a Non-Executive Director at Neuropharm Group Plc from 2007 to 2010.
He also worked as a Vice President for Clinical Development at Ligand UK Ltd. and as a Chief Medical Officer at Sarossa Capital Ltd.
Ehemalige bekannte Positionen von Gary Acton
| Unternehmen | Position | Ende |
|---|---|---|
Neuropharm Group Plc
 Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures speciality pharmaceuticals | Direktor/Vorstandsmitglied | 12.07.2010 |
| CTI BIOPHARMA CORP. | Corporate Officer/Principal | - |
| VERNALIS | Technik-/Wissenschafts-/F&E-Leiter | - |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Neuropharm Group Plc
Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures speciality pharmaceuticals | Health Technology |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
